Patents matching “anti-”

US 7282205

Anti-hepatitis A virus antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 16, 2007 · Expires Oct 11, 2027

US 7276227

Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Oct 2, 2007 · Expires Sep 27, 2027

US 7276643

Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents

The Regents of the University of California · Granted Oct 2, 2007 · Expires Sep 27, 2027

US 7264804

Kits for detecting anti-SIRS antibodies

Regents of the University of Minnesota · Granted Sep 4, 2007 · Expires Aug 30, 2027

US 7259278

Anti-S-phase tubulin ligands

Cytoskeleton, Inc. · Granted Aug 21, 2007 · Expires Aug 16, 2027

US 7256004

Variants of humanized anti-carcinoma monoclonal antibody CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 14, 2007 · Expires Aug 9, 2027

US 7255850

Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis

The Regents of the University of California · Granted Aug 14, 2007 · Expires Aug 9, 2027

US 7250169

Anti-tumor activity of Ea-4-peptide of pro-IGF-1

UNIVERSITY OF CONNECTICUT · Granted Jul 31, 2007 · Expires Jul 26, 2027

US 7205011

Anti-inflammatory activity of a specific turmeric extract

Board of Regents, Acting for and on behalf of, University of Arizona · Granted Apr 17, 2007 · Expires Apr 12, 2027

US 7198788

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.

The Board of Regents of the University of Texas System · Granted Apr 3, 2007 · Expires Mar 29, 2027

US 7189393

Recombinant anti-tumor RNAse

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 13, 2007 · Expires Mar 8, 2027

US 7183388

Anti-MUC-1 single chain antibodies for tumor targeting

The Regents of the University of California · Granted Feb 27, 2007 · Expires Feb 22, 2027

US 7141661

Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 28, 2006 · Expires Nov 23, 2026

US 7129332

Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 31, 2006 · Expires Oct 26, 2026

US 7118747

AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents

Pacific Northwest Biotechnology Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 5, 2006 · Expires Aug 31, 2026

US 7101863

Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative

BIODEX · Granted Sep 5, 2006 · Expires Aug 31, 2026

US 7081518

Anti-mesothelin antibodies having high binding affinity

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 25, 2006 · Expires Jul 20, 2026

US 7071168

Anti-cancer compounds and methods related thereto

The Regents of the University of Colorado · Granted Jul 4, 2006 · Expires Jun 29, 2026

US 7060686

Anti-inflammatory compounds derived from Pseudopterogorgia elisabethae

The Regents of the University of California · Granted Jun 13, 2006 · Expires Jun 8, 2026

US 7052705

Anti-angiogenic peptides

REGENERON PHARMACEUTICALS, INC. · Granted May 30, 2006 · Expires May 25, 2026

US 7025961

Anti-plasmodium composition and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Apr 11, 2006 · Expires Apr 6, 2026

US 7022720

Synthetic diazonamides as novel anti-mitotic agents

The Board of Regents of the University of Texas System · Granted Apr 4, 2006 · Expires Mar 30, 2026

US 7019135

Anti-viral pyrimidine nucleoside analogues

University College Cardiff Consultants Limited · Granted Mar 28, 2006 · Expires Mar 23, 2026